Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

Current Research in Parasitology & Vector-Borne Diseases, published by ELSEVIER, is an influential journal dedicated to advancing the understanding of parasitology and vector-borne diseases. With an ISSN of 2667-114X, this journal is highly esteemed in the field, holding a prestigious Q1 quartile ranking in categories such as Animal Science and Zoology, Insect Science, and Parasitology, as well as a notable Q2 ranking in Virology for 2023. The journal's focus spans a crucial intersection of disciplines, offering a platform for innovative research that directly addresses global health challenges posed by parasites and vectors. Researchers benefit from its robust open-access model, which facilitates unrestricted dissemination of knowledge, making essential findings accessible to a wider audience. The journal continues to play a pivotal role in fostering scholarly dialogue and interdisciplinary collaboration within the scientific community, serving as a vital resource for professionals, students, and academicians interested in the dynamic and evolving field of parasitology.

RISK ANALYSIS is a premier journal published by Wiley, focusing on the critical intersection of safety, risk, reliability, and quality within the fields of engineering and physiology. With a strong standing reflected in its Q1 category ranking in Safety, Risk, Reliability and Quality and Q2 in Physiology (medical), this journal is a vital resource for researchers, professionals, and students eager to stay informed on the latest methodologies, theories, and applications surrounding risk assessment and management. Since its inception in 1981, RISK ANALYSIS has been instrumental in shaping the discourse in its fields, garnering a robust reputation verified by its high rankings on Scopus, where it is positioned in the 85th percentile in Safety and the 77th percentile in Medicine. Though it does not currently offer Open Access options, the journal remains essential for those committed to advancing their understanding of risks associated with complex systems. For more insights, RISK ANALYSIS is available to readers throughout its converged years extending to 2024, solidifying its role as a foundational journal for impactful research.

Infectious Diseases Now is a premier academic journal dedicated to the evolving field of infectious diseases, published by Elsevier France - Éditions Scientifiques Médicales Elsevier. With an ISSN of 2666-9927 and an E-ISSN of 2666-9919, this journal stands at the forefront of disseminating critical research and clinical insights from 2021 to 2024. The journal's commitment to open access means that groundbreaking studies are readily available to researchers, healthcare professionals, and students, fostering a collaborative approach to tackling global health challenges. As evidenced by its Q2 quartile ranking in the 2023 Scopus category of Infectious Diseases, and its impressive position within the top 25% of its field, Infectious Diseases Now serves as an essential resource for those involved in the study and management of infectious diseases. By publishing high-quality research, case studies, and reviews, the journal plays a pivotal role in advancing knowledge and improving patient care in this vital area of medicine.

Microbiology Australia is a prominent journal published by CSIRO PUBLISHING, focusing on the diverse and rapidly evolving field of microbiology. Since its transition to Open Access in 2021, it has broadened its accessibility, fostering greater dissemination of research findings among scholars and practitioners. The journal features a range of topics that are pivotal for understanding microbial systems in applied microbiology, medical microbiology, public health, and environmental applications. Despite its current categorization in the Q4 quartile across several categories, it remains an essential platform for emerging research and innovative methodologies. Researchers and professionals can benefit from the journal's commitment to enriching the global discourse on microbiological advancements. With its ISSN 1324-4272 and E-ISSN 2201-9189, Microbiology Australia caters to a wide audience in Australia and beyond, making significant strides in bridging the gap between research and practical applications in microbiology.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

One Health Outlook is a dynamic open-access journal published by BMC, dedicated to advancing research and discourse within the interdisciplinary field of One Health. With a critical focus on the interconnectedness of human, animal, and environmental health, this journal provides a platform for scholarly discussions that address global health challenges. Launched in 2019 as an open-access resource, One Health Outlook aims to foster collaboration among researchers, practitioners, and policymakers, enabling them to share innovative solutions and data that influence health outcomes worldwide. Its commitment to making research freely accessible enhances its potential impact and reach, making it an invaluable resource for anyone engaged in One Health studies. The journal strives to bridge gaps in knowledge and promote best practices through high-quality research articles, review papers, and case studies, ensuring relevance in an ever-evolving health landscape.